Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2013 | 04-2013 | 01-2013 | 10-2012 | 07-2012 | |
| Operating Expenses | 3,054 | 5,477 | 2,181 | 0 | 3,583 |
| Operating Income | -3,054 | -5,477 | -2,181 | N/A | -3,583 |
| Interest Expense | 143 | 96 | 361 | 0 | 1,045 |
| Other Income | 1,601 | 296 | -3,891 | 0 | 1,524 |
| Pre-tax Income | -1,595 | -5,277 | -6,433 | 0 | -3,105 |
| Income Tax | N/A | N/A | -725 | N/A | N/A |
| Net Income Continuous | -1,595 | -5,277 | -5,708 | N/A | -3,105 |
| Net Income | $-1,595 | $-5,277 | $-5,708 | $N/A | $-3,105 |
| EPS Basic Total Ops | -443.78 | -1,547.23 | -1,979.01 | N/A | -1,427.29 |
| EPS Basic Continuous Ops | -400.60 | -1,495.87 | -1,920.40 | N/A | -1,341.85 |
| EPS Diluted Total Ops | -443.78 | -1,547.23 | -1,979.01 | N/A | -1,427.29 |
| EPS Diluted Continuous Ops | -400.60 | -1,495.87 | -1,920.40 | N/A | -1,341.85 |
| EBITDA(a) | $-3,005 | $-5,413 | $-2,115 | $N/A | $-3,312 |